Kirr Marbach & CO LLC Clear Point Neuro, Inc. Transaction History

Kirr Marbach & CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$7.8 - $11.6 $344,760 - $512,720	-44,200 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$11.08 - $18.86 $55,400 - $94,300	-5,000 Reduced 10.16%	44,200 $496,000
Q3 2021 Oct 28, 2021	BUY	$16.58 - $22.25 $66,320 - $89,000	4,000 Added 8.85%	49,200 $873,000
Q2 2021 Jul 19, 2021	BUY	$17.23 - $22.77 $89,596 - $118,404	5,200 Added 13.0%	45,200 $863,000
Q1 2021 Apr 19, 2021	SELL	$15.19 - $29.0 $33,418 - $63,800	-2,200 Reduced 5.21%	40,000 $846,000
Q1 2020 Apr 20, 2020	BUY	$3.33 - $6.14 $140,526 - $259,108	42,200 New	42,200 $218,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Kirr Marbach & CO LLC , based on Form 13F filings with the SEC.

Stay updated on Kirr Marbach & CO LLC with notifications on news.